Por: RTTNews Health September 25, 2023
Biopharmaceutical company Appili Therapeutics, Inc. (APLI.TO, APLIF.PK) announced Monday that its manufacturing and commercialization partner, Saptalis Pharmaceuticals, LLC received approval from the U.S. Food and Drug Administration (FDA) for Metronidazole Oral Suspension 500mg/5mL (ATI-1501).ATI-1501, Appili's liquid oral reformulation of the antibiotic metronidazole, has been licensed to Saptalis for commercialization in the U.S., and... + full article
Fox Business USA Business October 20, 2023
Check out what's clicking on FoxBusiness.com CVS said on Thursday that it is voluntarily removing certain common oral cough and cold products after a Food and Drug Administration (FDA) advisory panel determined last month that its active ingredient doesn't work. We... + más
Here’s why CVS was sued over fundraising fraud at checkout | The Boston Globe
'The Bachelor' season 27 cast revealed: Meet the ladies vying for Zach Shallcross' heart | ABC News
ABC News USA Health October 20, 2023
CVS Health is planning to remove one type of a common decongestant from shelves after earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for... + más
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
CVS removing decongestant from shelves after FDA panel says it's ineffective | ABC7
ABC7 USA World October 20, 2023
earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA... + más
CVS removing decongestant from shelves after FDA panel says it's ineffective | ABC News
New York Post USA Life September 15, 2023
The Food and Drug Administration (FDA) is taking the battle over Sudafed and other decongestants to the streets. The agency announced Thursday that it will allow the public to comment on the , the active ingredient in dozens of oral decongestants, simply doesn’t work. On... + más
Ineffective ingredient could make Dayquil, Sudafed and others disappear from store shelves | CBS News
Sudafed, Benadryl and most decongestants don’t work: FDA advisory panel | New York Post
CBS News USA Politics August 05, 2023
The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae by drugmakers Sage Therapeutics and Biogen. Zuranolone is approved for use in... + más
1st pill to treat postpartum depression moves to FDA for review | ABC News
FDA sets a decision date for Sage’s postpartum depression pill | The Boston Globe
RTTNews USA Health January 18, 2023
This commercial-stage biotechnology company developing next-generation, targeted antibody drug conjugates is aiming to achieve double-digit year-over-year revenue growth for its lead drug.The company we are profiling today is ADC Therapeutics SA () and the drug in focus is... + más
Nkarta | RTTNews
Chicago White Sox pitcher Liam Hendriks says he will undergo cancer treatment after being diagnosed with non-Hodgkin's lymphoma | CBS News
WPTV USA Nation November 30, 2022
If you or someone you love deals with a chronic disease, you're likely aware of injections. New research is indicating that in the not-too-distant future, that same medication and routine vaccinations might come in a pill form.For 10 years, biotech company has been working... + más
Op-Ed: Fentanyl pill producers used to mimic other pharmaceuticals, now they don't have to | Los Angeles Times
Hey FDA, Free the Birth Control Pill! | The Daily Beast
About iurex | Privacy Policy | Disclaimer |